| Title | Author(s) | Year | View Count |  | Biology of hepatocellular carcinoma | Pang, RWC; Joh, JW; Johnson, PJ; Monden, M; Pawlik, TM; Poon, RTP | 2008 | 106 |
| Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells. | Cheng, AS; Chan, HL; Leung, WK; Wong, N; Johnson, PJ; Sung, JJ | 2003 | 71 |
| Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals | Ng, EKO; Tsui, NBY; Lam, NYL; Chiu, RWK; Yu, SCH; Wong, SCC; Lo, ESF; Rainer, TH; Johnson, PJ; Lo, YMD | 2002 | 50 |
 | CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells | Lee, SP; Chan, ATC; Cheung, ST; Thomas, WA; CroomCarter, D; Dawson, CW; Tsai, CH; Leung, SF; Johnson, PJ; Huang, DP | 2000 | 254 |
| Novel intertypic recombinants of Epstein-Barr virus in the Chinese population | Midgley, RS; Blake, NW; Yao, QY; CroomCarter, D; Cheung, ST; Leung, SF; Chan, ATC; Johnson, PJ; Huang, D; Rickinson, AB; Lee, SP | 2000 | 286 |
| Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating epstein-barr virus DNA | Lo, YMD; Chan, ATC; Chan, LYS; Leung, SF; Lam, CW; Huang, DP; Johnson, PJ | 2000 | 89 |
| Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong | Cheung, ST; Leung, SF; Lo, KW; Chiu, KW; Tam, JSL; Fok, TF; Johnson, PJ; Lee, JCK; Huang, DP | 1998 | 37 |
| Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. | Cheung, ST; Lo, KW; Leung, SF; Chan, WY; Choi, PH; Johnson, PJ; Lee, JC; Huang, DP | 1996 | 34 |
|
